Biocon’s $1-billion biologics sales target ‘looks lofty’
Access in healthcare medication is a big concern globally and insulin prices have been soaring in recent years.from Stocks-Markets-Economic Times https://ift.tt/32Y3pVx
Cipla, PAG eye Wockhardt’s formulations business
Wockhardt employs more than 7,000 people and has a presence in the US, Britain, Ireland, Switzerland, France, Mexico, Russia and other countries. It has manufacturing and research facilities in India, the US and Britain, and a plant in Ireland. from Stocks-Markets-Economic Times https://ift.tt/2RO2P88
Comments
Post a Comment